Renaissance Technologies's GH Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 531,847 shares of Guardant Health, Inc. (GH) worth $33.23 M, representing 0.04% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in GH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 225,000 shares. Largest reduction occurred in Q2 2020, reducing 192,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2019 | +320,600 | New Buy | 320,600 | $63.83 |
| Q4 2019 | -320,600 | Sold Out | 320,600 | $0.00 |
| Q2 2020 | +128,300 | New Buy | 128,300 | $81.13 |
| Q3 2020 | -128,300 | Sold Out | 128,300 | $0.00 |
| Q4 2020 | +129,500 | New Buy | 129,500 | $128.88 |
| Q1 2021 | -42,000 | Reduce 32.43% | 87,500 | $152.65 |
| Q2 2021 | -87,500 | Sold Out | 87,500 | $0.00 |
| Q1 2023 | +213,400 | New Buy | 213,400 | $0.02 |
| Q2 2023 | -213,400 | Sold Out | 213,400 | $0.00 |
| Q3 2024 | +438,400 | New Buy | 438,400 | $22.94 |
| Q4 2024 | +64,700 | Add 14.76% | 503,100 | $30.55 |
| Q1 2025 | +113,400 | Add 22.54% | 616,500 | $42.60 |
| Q2 2025 | +58,700 | Add 9.52% | 675,200 | $52.04 |
| Q3 2025 | -143,353 | Reduce 21.23% | 531,847 | $62.48 |
Renaissance Technologies's Guardant Health Investment FAQs
Renaissance Technologies first purchased Guardant Health, Inc. (GH) in Q3 2019, acquiring 320,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Guardant Health, Inc. (GH) for 25 quarters since Q3 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Guardant Health, Inc. (GH) was in Q3 2024, adding 438,400 shares worth $10.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 531,847 shares of Guardant Health, Inc. (GH), valued at approximately $33.23 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.04% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Guardant Health, Inc. (GH) was 675,200 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.